Haverford Trust Co lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 7.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,517 shares of the financial services provider’s stock after selling 363 shares during the period. Haverford Trust Co’s holdings in […]
Midwest Professional Planners LTD. bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 22,075 shares of the financial services provider’s stock, valued at approximately $2,803,000. iShares Biotechnology ETF accounts for approximately 1.2% of […]
The U.S.-listed shares of Cellectis S.A. rocketed 179.3% on very heavy volume in premarket trading Wednesday, after the France-based biotechnology company.
Apollon Wealth Management LLC grew its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 11.3% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 10,104 shares of the financial services provider’s stock after buying an additional 1,029 shares during the period. Apollon Wealth Management LLC’s holdings […]